NIGMS News Releases

NIGMS is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. 

NIH is using $67.4 million to support to support highly innovative research projects promising big payoffs.

NIH will fund 14 grants focusing on factors that influence the careers of women
in biomedical and behavioral science and engineering.

Three NIGMS grantees will share the 2009 Nobel Prize for their “studies of the structure and function of the ribosome.”

Three NIGMS grantees will share the 2009 Nobel Prize for their discovery of "how chromosomes are protected by telomeres and the enzyme telomerase."

MIDAS adds new research expertise to simulate disease spread, evaluate different intervention strategies and help inform public health officials and policymakers.

A new study reports that a gene variant carried by about a third of the population plays a major role in this group’s response to an anti-clotting medicine, clopidogrel (Plavix). People with the variant produce a defective version of the CYP2C19 enzyme and are less able to activate the drug, placing them at increased risk for dangerous events like strokes and heart attacks.